Cargando…

Estrogen response in luminal breast cancer

Detalles Bibliográficos
Autores principales:	Rangel, Leticia B. A., Huang, Tim Hui-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	Editorial Material
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858541/ https://www.ncbi.nlm.nih.gov/pubmed/24077736

Ejemplares similares

Highlight report: Intratumoral metabolomic heterogeneity of breast cancer
por: Stoeber, Regina
Publicado: (2017)

Highlight report: Predicting late metastasis in breast cancer
por: Hammad, Seddik, et al.
Publicado: (2016)

Highlight report: Tumor infiltrating lymphocytes in breast cancer
por: Hellwig, Birte
Publicado: (2019)

Highlight report: Role of the circadian clock system in breast cancer
por: Ghallab, Ahmed
Publicado: (2015)

Prognostic signatures of breast cancer: Perou's molecular subtypes and Schmidt's metagenes
por: Cadenas, Cristina
Publicado: (2012)

Lung and breast cancer research: immunoglobulin Kappa C hits the headlines
por: Marchan, Rosemarie
Publicado: (2012)

Highlight report: Activating tumor-specific T-cells for breast cancer therapy
por: Gogiashvili, Mikheil
Publicado: (2018)

Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers
por: Williams, Michelle M., et al.
Publicado: (2018)

Highlight report: Relevance of T-cells, B-cells and immune checkpoint factors for prognosis of breast cancer
por: Myllys, Maiju
Publicado: (2019)

Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogramed primary prostate cancer cells.
por: Pollock, Claire B, et al.
Publicado: (2014)

Highlight report: Import of fatty acids by metastasizing tumor cells
por: Brecklinghaus, Tim
Publicado: (2018)

Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer
por: Arendt, Lisa M, et al.
Publicado: (2011)

Identification of carcinogens by a selected panel of DNA damage response associated genes
por: Stöber, Regina
Publicado: (2015)

Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer
por: Kumar, Sushil, et al.
Publicado: (2018)

Breaking Bad: how does a neuronal protein cause neuroendocrine cancer?
por: Pozo, Karine, et al.
Publicado: (2013)

Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?
por: Liu, Chia-Chia, et al.
Publicado: (2023)

Arrabidaea chica chloroform extract modulates estrogen and androgen receptors on luminal breast cancer cells
por: Brandão, Douglas C., et al.
Publicado: (2022)

Targeting IL-11 signaling in colon cancer
por: Ernst, Matthias, et al.
Publicado: (2013)

Highlight report: Occupational urinary bladder cancer
por: Bolt, H.M.
Publicado: (2017)

Interaction of genetic variants towards increased cancer risk
por: Hammad, Seddik
Publicado: (2013)

Highlight report: Validation of prognostic genes in lung cancer
por: Marchan, Rosemarie
Publicado: (2014)

Cancer research: from prognostic genes to therapeutic targets
por: Marchan, Rosemarie
Publicado: (2014)

Editor’s choice 2018: Non-coding RNAs in hepatocellular cancer
por: Ghallab, Ahmed
Publicado: (2020)

Highlight report: Functional consequences of urinary bladder cancer risk variants
por: Selinski, Silvia
Publicado: (2013)

Highlight report: Limits of prognostication of non-small cell lung cancer
por: Adawy, Alshaimaa
Publicado: (2017)

ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
por: Kalyuga, Maria, et al.
Publicado: (2012)

Genetic variants confer susceptibility to urinary bladder cancer: an updated list of confirmed polymorphisms
por: Selinski, Silvia
Publicado: (2012)

Highlight report: The relationship of DNA copy number alterations and mRNA levels in cancer
por: Hammad, Seddik
Publicado: (2017)

Relevance of genetic disposition versus environmental exposure for cancer risk: an old controversy revisited with novel methods
por: Bolt, H.M.
Publicado: (2013)

The post GWAS era: strategies to identify gene-gene and gene-environment interactions in urinary bladder cancer
por: Selinski, Silvia
Publicado: (2014)

Roles for estrogen and progesterone in breast cancer prevention
por: Jerry, D Joseph
Publicado: (2007)

Discovering urinary bladder cancer risk variants: Status quo after almost ten years of genome-wide association studies
por: Selinski, Silvia
Publicado: (2017)

Influence of framing on medical decision making
por: Gong, Jingjing, et al.
Publicado: (2013)

PROGNOSTIC IMPACT OF LOW ESTROGEN AND PROGESTERONE POSITIVITY IN LUMINAL B (HER2 NEGATIVE) BREAST CANCER
por: Rajc, Jasmina, et al.
Publicado: (2018)

Estrogen Receptor-Alpha and p53 Status as Regulators of AMPK and mTOR in Luminal Breast Cancer
por: Gandhi, Nishant, et al.
Publicado: (2021)

Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer?
por: Shupnik, Margaret A
Publicado: (2007)

Breast cancer survivals and hormone therapy: estrogen and melatonin
por: Soares, José Maria, et al.
Publicado: (2023)

Spherical nucleic acids for precision medicine
por: Mirkin, Chad A., et al.
Publicado: (2013)

Highlight report: Software for tissue analysis and reconstruction
por: Haridy, Mohie A. M., et al.
Publicado: (2015)

Gebel-criteria for risk assessment in nanotoxicology
por: Hammad, Seddik, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o2f145vb7jiravrmsurk9c7v4r